<DOC>
	<DOCNO>NCT03073109</DOCNO>
	<brief_summary>This study aim describe outcomes related physical activity , activity disease , quality life , work productivity safety Latin-American patient Rheumatoid Arthritis ( RA ) treat tofacitinib biological DMARDs failure respond conventional DMARDs real-life condition . This non-interventional , hybrid study ( prospective retrospective data collection ) compare tofacitinib biologic DMARD treatment patient RA failure conventional DMARDs . The population compose adult patient 18 year age diagnose RA prescribe tofacitinib biological DMARDs .</brief_summary>
	<brief_title>Patient-Reported Outcomes In Rheumatoid Aarthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs ( DMARDs ) In Real Life Conditions</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Patients ≥ 18 year age time recruitment Patient diagnose moderate severe RA ≥ 6 month enrollment Patients inadequate response continuous use methotrexate combination conventional DMARDs least 12 week study without dose change within last 8 week enrollment study . Patients biological DMARDs use patient history . Patients newly prescribe tofacitinib biological DMARDs dos establish ACR guideline follow medical criterion . Acceptance patient participate study sign informed consent . Patients ability answer questionnaire kind mental disorder may affect answer . Patients diagnose autoimmune rheumatic disease RA Sjogren 's syndrome . Patients treat biological DMARDs monotherapy . Participation study involve investigational drug ( ) ( Phases 14 ) within 4 week 5 halflives ( whichever longer ) discontinuation investigational compound current study begin and/or study participation . Patients current malignancy history malignancy , exception adequately treat excised nonmetastatic basal cell squamous cell cancer skin cervical carcinoma situ . Patients lymphoproliferative disorder ( e.g. , Epstein Barr Virus ( EBV ) relate lymphoproliferative disorder ) , history lymphoma , leukemia , sign symptoms suggestive current lymphatic disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>